swisspartners Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
swisspartners Advisors's ABBV Position: Q4 2023 in Review
swisspartners Advisors sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 83,098 shares — an estimated $11.3M sold.
swisspartners Advisors first reported a position in ABBV in Q4 2019 and held it in 16 quarters. The position peaked at $16.5M in Q1 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.
- swisspartners Advisors reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
- swisspartners Advisors sold 83,098 AbbVie shares in Q4 2023, an estimated $11.3M.
- swisspartners Advisors first reported a position in AbbVie in Q4 2019 and held it in 16 quarters.
- swisspartners Advisors's AbbVie position peaked at $16.5M in Q1 2022.
- 3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.
Based on swisspartners Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.